148 related articles for article (PubMed ID: 9841272)
1. Acute Leukemia Forum '98. Advances and controversies in the biology and treatment of acute myelogenous leukemia and myelodysplasia. Symposium proceedings. San Francisco, California, USA. March 6, 1998.
Leukemia; 1998 Sep; 12 Suppl 1():S1-56. PubMed ID: 9841272
[No Abstract] [Full Text] [Related]
2. Advances and controversies in the biology and therapy of acute leukaemia and myelodysplasia.
Rowe JM
Best Pract Res Clin Haematol; 2009 Dec; 22(4):475-8. PubMed ID: 19959095
[No Abstract] [Full Text] [Related]
3. Advances in the biology and therapy of acute myelogenous leukemia. Selection of keynote addresses from the Acute Leukemia Forum 2007. March 23, 2007. San Francisco, California, USA.
Best Pract Res Clin Haematol; 2008 Mar; 21(1):1-98. PubMed ID: 18561374
[No Abstract] [Full Text] [Related]
4. Recent progress in acute leukemia and myelodysplasia.
Carraway HE; Pollyea DA; Stein EM
Best Pract Res Clin Haematol; 2022 Dec; 35(4):101415. PubMed ID: 36517125
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with myelodysplasia-related changes demonstrating prominent basophilic differentiation.
Bahmanyar M; Chang H
Blood; 2016 May; 127(20):2503. PubMed ID: 28092887
[No Abstract] [Full Text] [Related]
6. Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes.
Schildgen V; Wulfert M; Gattermann N
Exp Hematol; 2011 Jun; 39(6):666-675.e1. PubMed ID: 21447369
[TBL] [Abstract][Full Text] [Related]
7. Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.
Davies JK; Hassan S; Sarker SJ; Besley C; Oakervee H; Smith M; Taussig D; Gribben JG; Cavenagh JD
Br J Haematol; 2018 Feb; 180(3):346-355. PubMed ID: 29076145
[TBL] [Abstract][Full Text] [Related]
8. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.
Ballen KK; Antin JH
Hematol Oncol Clin North Am; 1993 Apr; 7(2):477-93. PubMed ID: 8468276
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly.
Klepin HD
Clin Geriatr Med; 2016 Feb; 32(1):155-73. PubMed ID: 26614866
[TBL] [Abstract][Full Text] [Related]
10. A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.
Hu KX; Sun QY; Guo M; Qiao JX; Yu CL; Qiao JH; Dong Z; Sun WJ; Zuo HL; Huang YJ; Cai B; Ai HS
Stem Cells Transl Med; 2016 Apr; 5(4):524-9. PubMed ID: 26838271
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients.
Devillier R; Gelsi-Boyer V; Murati A; Prebet T; Rey J; Etienne A; D'Incan E; Charbonnier A; Blaise D; Mozziconacci MJ; Vey N
Am J Hematol; 2015 Jan; 90(1):E22-4. PubMed ID: 25219760
[No Abstract] [Full Text] [Related]
12. Acute Leukemia Forum '99: Advances and Controversies in the Therapy of Acute Myeloid Leukemia. San Francisco, California, USA. 16 April 1999. Proceedings.
Leukemia; 2000 Mar; 14(3):466-517. PubMed ID: 10755889
[No Abstract] [Full Text] [Related]
13. Treatment of acute myelogenous leukemia and myelodysplastic syndromes.
Estey EH
Semin Hematol; 1995 Apr; 32(2):132-51. PubMed ID: 7652581
[No Abstract] [Full Text] [Related]
14. Acute Leukemia Forum '95: Advances and Controversies in Induction Therapy and Treatment of Older Adults with AML. Symposium proceedings. San Francisco, California, USA, November 10, 1995.
Leukemia; 1996 Apr; 10 Suppl 1():S1-48. PubMed ID: 8618460
[No Abstract] [Full Text] [Related]
15. Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia.
Bertz H; Spyridonidis A; Ihorst G; Engelhardt M; Grüllich C; Wäsch R; Marks R; Finke J
Biol Blood Marrow Transplant; 2012 Jun; 18(6):894-902. PubMed ID: 22108569
[TBL] [Abstract][Full Text] [Related]
16. Familial myelodysplastic syndrome/acute myeloid leukemia.
Churpek JE
Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
[TBL] [Abstract][Full Text] [Related]
17. Fanconi Anemia patient with AML1 gene amplification and monosomy 7 in pre-transplant myelodysplasia (MDS) relapsing 7 years after successful allo-SCT.
Ayas M; Walter C
Bone Marrow Transplant; 2008 Oct; 42(8):555-7. PubMed ID: 18622412
[No Abstract] [Full Text] [Related]
18. [Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality].
Calderón-Cabrera C; Falantes JF; Bernal R; Pérez-Simón JA
Med Clin (Barc); 2015 Sep; 145(5):224-6. PubMed ID: 25190583
[No Abstract] [Full Text] [Related]
19. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
Caron PC; Dumont L; Scheinberg DA
Clin Cancer Res; 1998 Jun; 4(6):1421-8. PubMed ID: 9626458
[TBL] [Abstract][Full Text] [Related]
20. [Leukemias and malignant lymphomas in children].
Schmiegelow K
Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
[No Abstract] [Full Text] [Related]
[Next] [New Search]
